Peers of Neurogene Inc (NGNE)
Side-by-side comparison
Health Care · Biotechnology
Enterprise value divided by trailing twelve-month revenue. A capital-structure-neutral sales valuation metric.
Latest EV/Sales
-55.43x
As of Jun 27, 2025
Beyond EV/Sales, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | EV/Sales |
|---|---|
| Jun 27, 2025 | -55.43x |
| Jun 26, 2025 | -48.81x |
| Jun 25, 2025 | -43.81x |
| Jun 24, 2025 | -38.65x |
| Jun 23, 2025 | -38.32x |
| Jun 20, 2025 | -29.61x |
| Jun 18, 2025 | -20.89x |
| Jun 17, 2025 | -18.96x |
EV/Sales = Enterprise Value / Revenue (TTM). Enterprise Value = Market Cap + Total Debt − (Cash & Short-Term Investments + Long-Term Investments).
EV/Sales is particularly useful in M&A analysis and for companies with significant debt.
Read the general EV/Sales definition, formula, and analyst usage guide.
EV/Sales guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison